SERB is a global specialty pharmaceutical company with a growing portfolio of medicines for emergency care & rare diseases. For over 30 years we have made treating these complex & life-threatening conditions possible, supporting clinicians, healthcare systems & governments while offering hope to patients & their families. SERB is a leading provider of essential acute care medicines, addressing unmet medical needs & supplying antidotes/ medical countermeasures for chemical, biological, radiological & nuclear (CBRN) risks